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Abstract
The well-established European Journal of Medical Research has joined BioMed Central’s portfolio of journals in
January 2012, converting to the open access publishing model. Since its launch in 1995 the journal has been a
print-only publication; from now on, it continues as an open access, online-only journal. The conversion to open
access opens up the potential for the journal to become a leading, globally visible title in the field of general
medicine over the coming years.
Editorial
As of today, at the outset of its 17
th volume, the Eur-
opean Journal of Medical Research is an open access
publication, having joined BioMed Central’s portfolio of
journals. The change in the publishing model awards
this well-established title with an opportunity to develop
into a leading general medicine journal over the coming
years.
Founded by the Munich-based publishing house Hol-
zapfel Verlag in 1995, the journal soon became a
respected and broadly indexed resource. Until the end
of 2011, however, the journal remained a print-only
publication. While many other aspects of the journal
will continue without change, the publishing ‘format’ is
now changing, from print-only to online-only and from
subscription-based economics to the open access model
with article processing charges borne, after peer review
and upon acceptance, by authors’ home institutions or
research funders. The rapid growth of high-quality open
access publications is rooted in the fact that an increas-
ing number of universities, funding agencies and gov-
ernmental agencies support or even mandate open
access, in different ways and through different means.
The journal’s new publisher, BioMed Central (Spring-
er’s imprint for open access journals in biology and
medical disciplines) has over recent years accumulated a
wealth of experience with journal transfers and conver-
sions to open access. A rapidly growing number of jour-
nals in BioMed Central’s portfolio moved there from
other publishing arrangements. In such cases, a clear
trend has emerged that shows an increase of these jour-
nals’ impact factors after two to three years when the
open access articles start forming the basis of the calcu-
lations. Higher visibility and unrestricted access lead to
increased impact [1], of which the impact factor is only
one aspect. Taken as a proxy, however, it serves as an
indicator of the effect of open access on visibility and
usage. Cases in point are Acta Veterinaria Scandinavica,
which has seen its impact factor quadruple since its
move to BioMed Central in 2006, and Journal of Cardio-
vascular Magnetic Resonance, another long-established
society publication, which has seen its impact factor
almost treble to 4.3 three years after it became an open
access title [2].
We are optimistic that we can achieve a similar effect
for European Journal of Medical Research,a n dt h eE d i -
torial Board and BioMed Central as the publisher will
work together to achieve this. As a first step towards
this aim, the new publisher has converted the technical
format of all articles published in the journal in 2010
and 2011 to make them freely available for a global
readership.
While the scope of the journal remains unchanged,
with continued focus on clinical research, there is from
now on unrestricted ‘space’ to publish articles from
across the full spectrum of medical disciplines, with no
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ability of research that falls into the journal’ss c o p e ,t h e
only restricting factor is quality, and the guardians of
quality are the members of the Editorial Board. Future
changes of the size and composition of the board will
reflect a number of factors, such as the overall growth
of the journal, the ‘share’ of articles from the diversity of
medical subjects, and the objective to build a truly pan-
European base for the journal.
The journal’s success story since its launch 17 years
ago is the achievement of its founders and editors, Fer-
dinand Holzapfel, Monika Ortner-Bach, and Professor
Nepomuk Zöllner as the first Editor-in-Chief, together
with so many colleagues who contributed and continue
to contribute as authors, editors, and reviewers. The
future of European Journal of Medical Research lies in
open access. What further changes will we see as a
result of its re-launch as an open access journal? Which
new audiences will it find, and which medical disciplines
will be most represented among the publications? We
are curious to find out over the coming years, and this
curiosity is based on our confidence that the conversion
to open access and online publishing puts the journal in
a strong position to continue its success story. We look
forward to work with ‘old’ and ‘new’ colleagues on this
new chapter in the story entitled ‘European Journal of
Medical Research’.
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